Skip to main content
VCbacked
Log inGet Started

Integra Therapeutics

Barcelona, Spain

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

$3.2M raised
Sep 2025
Seed
BiotechnologyGeneticsHealth Care

Top Investors

Columbus Venture PartnersEuropean Innovation Council FundInvivo Capital PartnersAdBio partnersCDTI Innovación's INNVIERTE program

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Integra Therapeutics

How much funding has Integra Therapeutics raised?
Integra Therapeutics has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Who are Integra Therapeutics's investors?
Integra Therapeutics's investors include Columbus Venture Partners, European Innovation Council Fund, Invivo Capital Partners, AdBio partners, CDTI Innovación's INNVIERTE program.
Where is Integra Therapeutics headquartered?
Integra Therapeutics is headquartered in Barcelona, Spain.
What does Integra Therapeutics do?
Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
What stage is Integra Therapeutics at?
Integra Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Integra Therapeutics — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/integra-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). Integra Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/integra-therapeutics
Wikipedia (cite web)
{{cite web |title=Integra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/integra-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong